Patents
Literature
1 results about "Methyl xanthine" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Xanthine is produced naturally by both plants and animals. The methylxanthines, theophylline, and dyphylline are used in the treatment of airways obstruction caused by conditions such as asthma, chronic bronchitis, or emphysema.
Mixture of human milk oligosaccharides and bifidomacterium longum infantis
PCT designated stageWO2026109326A1Organic active ingredientsMetabolism disorderMetaboliteMethyl xanthine
The present invention provides a combination of Bifidobacterium longum subsp. infantis, lacto- N-fucopentaose I (LNFP-I) and a HMO mixture for use in therapy by promoting the production of one or more beneficial metabolites selected from uridine, adenine, guanine, AMP, cAMP, 4-guanidinobutyric acid, p-hydroxyphenyllactic acid, acetyl-carnitine and 3-methylxanthine in the gastrointestinal tract of an infant or young child, wherein the HMO mixture consists of 2'- fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and optionally 3-fucosyllactose (3FL) and / or lacto-N-neotetraose (LNnT).
Owner:SOCIETE DES PRODUITS NESTLE SA